The effects of apixaban on clot characteristics in atrial fibrillation: A novel pharmacodynamic biomarker

The effects of apixaban on clot characteristics in atrial fibrillation: A novel pharmacodynamic biomarker

Abstract Atrial fibrillation (AF) is a major risk factor for stroke. We aim to characterize AF patients and the effects of apixaban therapy in terms of clot microstructure using gel point analysis, a novel biomarker. Seventy‐eight patients were included in the study, 50 Stroke with AF (AF‐S), and 28...

Full description

Bibliographic Details
Main Authors: Matthew J. Lawrence, Vanessa Evans, Janet Whitley, Suresh Pillai, Phylip R. Williams, James Coulson, Manju Krishnan, Peter Slade, Kieron Power, Roger H.K. Morris, Phillip A. Evans
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:Pharmacology Research & Perspectives
Subjects:
anticoagulation
apixaban
cerebrovascular disease
clot microstructure
gel point and fractal analysis
Online Access:https://doi.org/10.1002/prp2.937

Internet

https://doi.org/10.1002/prp2.937

Similar Items